Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaadvancedresearchcompany

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Sobha, Chennai Petroleum Corporation, Piramal Enterprises, SPARC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying Sobha, Chennai Petroleum Corporation, Piramal Enterprises and SPARC.

    • Buy Sun Pharma, Escorts; sell Indiabulls Real Estate, United Spirits: Thakkar

      Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Sun Pharma and Escorts and can sell Indiabulls Real Estate, United Spirits and Strides Shasun.

    • Nifty @ record high; Time to Buy or Book Profits? 4 stocks which can give up to 24% return

      Indices may pause around 10,200-10,250 levels for few days and may consolidate but any profit booking/retracement can be used to accumulate fresh longs with targets of 10350-10400 levels.

    • Bull's Eye: Buy Yes Bank, L&T Finance, Pidilite, Adani Power, CESC; sell NCC

      Ruchit Jain of Angel Broking advises buying Pidilite Industries with a target of Rs 855.

    • Bull's Eye: Buy HPCL, CG Power, SPARC, United Spirits, CONCOR, CG Power; sell JSPL

      Jay Thakkar of Anand Rathi Securities is of the view that one may buy United Spirits with a target of Rs 2720.

    • Buy Tata Global Beverage, Sun Pharma Advanced, IndusInd Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Tata Global Beverage, Sun Pharma Advanced Research Company and IndusInd Bank.

    • Buy Sun Pharma Advanced Research, Godrej Consumer, Karnataka Bank: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma Advanced Research Company, Godrej Consumer and Karnataka Bank.

    • Buy Bajaj Finance, SPARC, Adani Power, Bhushan Steel, State Trading Corp: Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying Bajaj Finance, Sun Pharma Advanced Research, Adani Power, Bhushan Steel and State Trading Corporation of India.

    • Bull's Eye: Buy HUL, Biocon, SRF, Godrej Consumer, SPARC, GSFC; Sell Ajanta Pharma

      Ashish Kyal of Waves Strategy Advisors is of the view that one may buy Biocon with a target of Rs 418.

    • Buy HPCL, Divis Labs, SPARC, Capital First, Idea Cellular, Welspun Corp: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying HPCL, Divis Laboratories, SPARC, Capital First, Idea Cellular and Welspun Corp.

    • Bull's Eye: Buy Indian Bank, DLF, SPARC, Just Dial, Dhampur Sugar, SREI Infra

      Sumeet Jain of Destimoney Securities suggests buying Sun Pharma Advanced with a target of Rs 354.

    • Bull's Eye: Buy Biocon, Nalco, GSPL, SPARC; sell IOC, Divis Lab

      Vishal Malkan of malkansview.com advises selling Power Finance Corporation with target of Rs 115.

    • Nifty may remain volatile ahead of expiry; 4 stocks to pick today: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that crucial support for the Nifty is at 9520-9466 and the resistance is at 9620-9700-9724 and has Mindtree and Sun Pharma as bullish plays while he has Tech Mahindra and UPL as bearish plays.

    • Sell Aurobindo Pharma, Sun Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests selling Aurobindo Pharma and Sun Pharma.

    • Bull's Eye: Buy PNB, Godrej Industries, Wockhardt, Just Dial, SPARC

    • Buy Sun Pharma Adv, Manpasand Beverage, IGL: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma Advanced Research Company, Manpasand Beverage and Indraprastha Gas.

    • Sell Dabur, Vedanta; buy Sun Pharma Advanced Research: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may sell Dabur India and Vedanta and buy Sun Pharma Advance Research Company.

    • Bull's Eye: Buy Hexaware, Siemens, Biocon; sell BoI, Jet, JSPL

      Ruchit Jain of Angel Broking is of the view that one may buy Siemens with a target of Rs 1170.

    • Sell Marico, buy Sun Pharma Advanced Research: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can sell Marico and buy Sun Pharma Advanced Research Company.

    • Bull's Eye: Buy Adani Ports, CESC, SPARC, NCC; sell Voltas

      Gaurav Ratnaparkhi of Sharekhan advises buying CESC with a target of Rs 655.

    • Here are a few stock ideas from Prakash Diwan

      In an interview to CNBC-TV18, Prakash Diwan of prakashdiwan.in shared his readings and outlook on specific stocks and sector.

    • Buy Tata Steel, sell Infosys: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one may buy Tata Steel and advises selling Infosys.

    • Cadila Healthcare may test Rs 393: Rajat Bose

      Rajat Bose of rajatkbose.com feels that Cadila Healthcare may test Rs 393.

    • Buy SPARC, says Mitesh Thacker

      Mitesh Thacker of miteshthacker.com advises buying Sun Pharma Advanced Research Company.

    • Bull's Eye: Buy Castrol, Biocon, Hexaware, SPARC, Jet

      Vishal Malkan of malkansview.com is of the view that one may buy Shriram Transport Finance Corporation with a target of Rs 1300.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347